A nurse is caring for a client who asks why she is being prescribed aspirin 325 mg daily following a myocardial infarction. The nurse should instruct the client that aspirin is prescribed for clients who have coronary artery disease for which of the following effects?

Choice C rationale Aspirin (acetylsalicylic acid) is primarily prescribed after a myocardial infarction (MI) for its antiplatelet effects. It works by irreversibly inhibiting the cyclooxygenase (COX) enzyme in platelets, thus preventing the synthesis of thromboxane A2 (TXA_2). TXA_2 is a potent vasoconstrictor and platelet aggregator; blocking it prevents further thrombus formation in coronary arteries, reducing the risk of a recurrent MI. Choice A rationale While aspirin is a mild antipyretic (fever reducer), this is not the primary therapeutic goal following a myocardial infarction. Fever prevention is achieved through the central inhibition of prostaglandin E_2 (PGE_2) synthesis in the hypothalamus, but the life-saving mechanism is antiplatelet aggregation. Choice B rationale Aspirin is a non-opioid analgesic (pain reliever) due to its peripheral inhibition of prostaglandin synthesis, which reduces pain sensitization. However, the mild analgesic effect of 325 mg of aspirin is not the primary reason for its daily, long-term prescription in coronary artery disease; pain management is typically addressed with other medications acutely. Choice D rationale Aspirin is an anti-inflammatory agent due to its inhibition of prostaglandin synthesis at the site of inflammation. While chronic inflammation is implicated in atherosclerosis, this mechanism is secondary. The most critical, immediate, and life-saving rationale for daily dosing after MI is the antiplatelet action to prevent thrombotic occlusion.